Sentinel node metastasectomy in thin ≤1-mm melanoma

Langenbeck's Archives of Surgery

Volumn 390, Issue 5, 2005, Pages 403-407

  Koskivuo, Ilkka ^a   Suominen, Erkki ^a   Niinikoski, Juha ^a   Talve, Lauri ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Melanoma; Metastasectomy; Sentinel lymph node; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 24344435615     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-005-0572-5     Document Type: Article

References (30)

1. Gould EA, Winship T, Philbin PH, Kerr HH (1960) Observations on a "sentinel node" in cancer of the parotid. Cancer 13:77-78
2. Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 39:456-466
3. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399
4. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, Cavaliere R, Mozzillo N, Rossi CR, MacKie RM, Nieweg O, Pace M, Kirov K (2000) Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7:469-474
5. Schulze T, Bembenek A, Schlag PM (2004) Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbeck's Arch Surg 389:532-550
6. Essner R, Conforti A, Kelley MC, Wanek L, Stern S, Glass E, Morton DL (1999) Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6:442-449
7. Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H (2004) Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. Eur J Surg Oncol 30:851-856
8. Agnese DM, Abdessalam SF, Burak WE Jr, Magro CM, Pozderac RV, Walker MJ (2003) Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 134:542-547
9. Bedrosian I, Faries MB, Guerry D, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJ (2000) Incidence of sentinel node metastasis in patients with thin primary melanoma (< or =1 mm) with vertical growth phase. Ann Surg Oncol 7:262-267
10. Bleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL (2003) Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 21:1326-1331
11. Lowe JB, Hurst E, Moley JF, Cornelius LA (2003) Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol 139:617-621
12. Nahabedian MY, Tufaro AP, Manson PN (2003) Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Ann Plast Surg 50:601-606
13. Stitzenberg KB, Groben PA, Stern SL, Thomas NE, Hensing TA, Sansbury LB, Ollila DW (2004) Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness ≤1.0 mm). Ann Surg Oncol 11:900-906
14. Topping A, Dewar D, Rose V, Cavale N, Allen R, Cook M, Powell B (2004) Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience. Br J Plast Surg 57:97-104
15. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648
16. Corsetti RL, Allen HM, Wanebo HJ (2000) Thin ≤1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol 7:456-460
17. Leiter U, Buettner PG, Eigentler TK, Garbe C (2004) Prognostic factors of thin cutaneous melanoma: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. J Clin Oncol 22:3660-3667
18. Nguyen CL, McClay EF, Cole DJ, O'Brien PH, Gillanders WE, Metcalf JS, Maize JC, Baron PL (2001) Melanoma thickness and histology predict sentinel lymph node status. Am J Surg 181:8-11
19. Oliveira Filho RS, Ferreira LM, Biasi LJ, Enokihara MM, Paiva GR, Wagner J (2003) Vertical growth phase and positive sentinel node in thin melanoma. Braz J Med Biol Res 36:347-350
20. Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y (2003) Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 97:1488-1498
21. Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ (2004) The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11:426-433
22. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2004) An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:131-149
23. Gimotty PA, Guerry D, Ming ME, Elenitsas R, Xu X, Czerniecki B, Spitz F, Schuchter L, Elder D (2004) Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 22:3668-3676
24. Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM (2004) Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11:247-258
25. Jacobs LA, Chang CK, DasGupta TK, Salti GI (2003) Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma. Ann Surg Oncol 10:558-561
26. Statius Muller MG, van Leeuwen PA, van Diest PJ, Vuylsteke RJ, Pijpers R, Meijer S (2001) No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res 11:303-307
27. Zapas JL, Coley HC, Beam SL, Brown SD, Jablonski KA, Elias EG (2003) The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. J Am Coll Surg 197:403-407
28. Essner R, Lee JH, Wanek LA, Itakura H, Morton DL (2004) Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 139:961-966
29. Ollila DW, Hsueh EC, Stern SL, Morton DL (1999) Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 71:209-213
30. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter selective lymphadenectomy trial group. Ann Surg 230:453-463